New Mechanisms in Diisocyanate-mediated Allergy/toxicity: Are MicroRNAs in Play?
Supporting Files
-
April 2025
-
Available in CDC Stacks on April 01, 2025, 12:00 AM
File Language:
English
Details
-
Alternative Title:Current Opinion in Allergy and Clinical Immunology, 2025, v. 25, no. 2: New Mechanisms in Diisocyanate-mediated Allergy/toxicity: Are MicroRNAs in Play?
-
Journal Article:Current Opinion in Allergy and Clinical Immunology
-
Personal Author:
-
Description:To describe recent findings of diisocyanate-mediated mechanisms in allergy and toxicology by addressing the role of microRNA (miR) in immune responses that may contribute to the development of occupational asthma (OA).
Studies of diisocyanate asthma have traditionally focused on the immune and inflammatory patterns associated with diisocyanate exposures; however, recognized knowledge gaps exist regarding the detailed molecular mechanism(s) of pathogenesis. Recent studies demonstrate the critical role endogenous microRNAs play as gene regulators in maintaining homeostasis of the human body, and in the pathophysiology of many diseases including asthma. Given that diisocyanate-OA shares many pathophysiological characteristics with asthma, it is likely that miR-mediated mechanisms are involved in the pathophysiology of diisocyanate-OA. Recent reports have shown that changes in expression of endogenous miRs are associated with exposure to the occupationally relevant diisocyanates, toluene diisocyanate (TDI) and methylene diphenyl diisocyanate (MDI). Continued mechanistic study of these relevant miRs may lead to the development of novel biomarkers of occupational exposure and/or provide efficacious targets for therapeutic strategies in diisocyanate asthma.
The molecular mechanisms underlying diisocyanate-OA pathophysiology are heterogeneous and complicated. In this review, we highlight recent research into the roles and potential regulation of miRs in diisocyanate-OA. -
Content Notes:Author manuscript
-
Subjects:
-
Keywords:
-
Source:Current Opinion in Allergy and Clinical Immunology, 2025, v. 25, no. 2
-
DOI:
-
ISSN:1528-4050 ; 1473-6322
-
Pubmed ID:39450940
-
Pubmed Central ID:PMC11867871
-
Document Type:
-
Funding:
-
Genre:
-
Pages in Document:75-82 (13 pdf pages)
-
Volume:25
-
Issue:2
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:dfbfa087692d82ae0ab2d23ea0f5a7769c14a70c2865f5d6062a9b41d5bb6b03e6d36b12d7a65c7e5826314d2195e943e939eddb4d77596facfdefa91e55f5ad
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access